This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Jun;15(3):74-5.

doi: 10.1136/ebm1070.

Rosuvastatin is similarly effective for primary prevention of cardiovascular disease in women as in men

Andrew Leventhal¹, Erin D Michos

Affiliations

PMID: 20522679
DOI: 10.1136/ebm1070

Comment

Rosuvastatin is similarly effective for primary prevention of cardiovascular disease in women as in men

Andrew Leventhal et al. Evid Based Med. 2010 Jun.

. 2010 Jun;15(3):74-5.

doi: 10.1136/ebm1070.

Authors

Andrew Leventhal¹, Erin D Michos

Affiliation

¹ Johns Hopkins University School of Medicine, Bethesda, Maryland, USA.

PMID: 20522679
DOI: 10.1136/ebm1070

No abstract available

PubMed Disclaimer

Comment on

Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials.
Mora S, Glynn RJ, Hsia J, MacFadyen JG, Genest J, Ridker PM. Mora S, et al. Circulation. 2010 Mar 9;121(9):1069-77. doi: 10.1161/CIRCULATIONAHA.109.906479. Epub 2010 Feb 22. Circulation. 2010. PMID: 20176986 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.